Credit Suisse’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-12,313
| Closed | -$42K | – | 3550 |
|
|
2017
Q1 | $42K | Sell |
12,313
-1,866
| -13% | -$6.37K | ﹤0.01% | 3382 |
|
|
2016
Q4 | $73K | Buy |
14,179
+11,751
| +484% | +$60.5K | ﹤0.01% | 3625 |
|
|
2016
Q3 | $61K | Sell |
2,428
-497
| -17% | -$12.5K | ﹤0.01% | 3653 |
|
|
2016
Q2 | $73K | Buy |
2,925
+606
| +26% | +$15.1K | ﹤0.01% | 3797 |
|
|
2016
Q1 | $68K | Sell |
2,319
-7,078
| -75% | -$208K | ﹤0.01% | 3569 |
|
|
2015
Q4 | $349K | Buy |
9,397
+5,056
| +116% | +$188K | ﹤0.01% | 3385 |
|
|
2015
Q3 | $212K | Sell |
4,341
-606
| -12% | -$29.6K | ﹤0.01% | 3686 |
|
|
2015
Q2 | $341K | Buy |
+4,947
| New | +$341K | ﹤0.01% | 3673 |
|
|
2015
Q1 | – | Sell |
-4,000
| Closed | -$51K | – | 4257 |
|
|
2014
Q4 | $51K | Sell |
4,000
-19
| -0.5% | -$242 | ﹤0.01% | 4135 |
|
|
2014
Q3 | $61K | Buy |
+4,019
| New | +$61K | ﹤0.01% | 3946 |
|